The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Afternoon all
I want to get 300k shares Monday. I find the tone on this board the most admirable and feel there are some real genuine holders, well researched and happy to share info, rather than scrubble ae call, ramp and deramp.
I'm not sure of an exit though as seems there is a lot of upside short and long term.
I'll be looking at the posts more once I take the plung Monday
This is not correct. Other factors determine market value. You may find that we get a Tr1, or that the price goes up. Remember this is not like most companies, this is operating at fast pace, responding to a global problem. All sorts of news due shortly
'within the next few weeks. These Affimer binders will also be transferred to Cytiva shortly for implementation in a point-of-care test strip, similar in appearance to a pregnancy test, giving a visual read-out in minutes using a sample such as saliva.'
Avacta have experience with affirmers for over a decade. I believe there is no IF to the success of this testing strip its when.
From what I have read they provide Affimer based licensed solutions all day long, it's their business. They are known for it. They know where it can be used. CYTEVIA would not of approached them otherwise. Sp terraces due to traders wanting a quick buck. They will probably start to pile back in next week. Many see this as a long term hold. Soon this short limbo period will be behind us genuine holders
The key potential here is if this affirmer based effective and reliable. I feel the risk and reward ratio here are in any investors favour at these price levels. The closer to news we get the more doubts people will bring to this board. I believe the key was Avacta's work with the Zika virus. Can anyone here suggest that the covid 19/SARS strain works differently?
From their website
Avacta is already generating Affimer reagents that detect the COVID-19 virus and together with Cytiva will develop and manufacture a test capable of diagnosing the infection in minutes using a respiratory sample such as saliva.
Notice the word WILL after Cytiva
Everything has to be carefully worded in interviews. But the fact the CEO is on the marketing bandwagon eves dropping their partners name GE medical and the fact they have proven affirmer experience and a proven track record in this field shows me its like asking mo farrah to run a marathon in India and doubting he can do it because he hasn't ran in India before
Seems people are a little frustrated with lack of sp movement. This just will take one rns to get a rocket up it. It's a product designed specifically for the number one need right now. It has backing from the best of the best in the morning in the medical field. It solves price, time, convience problem. It will get the economy back to normality. Only the wise can see where this is going